Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 25 August 2009, doi:10.1136/bmj.b3107
Cite this as: BMJ 2009;339:b3107
Consensus from clinicians and researchers on management is urgently needed
| The first 150 words of the full text of this article appear below. |
Incidental findings on brain imaging are defined as previously undetected abnormalities of potential clinical relevance that are unexpectedly discovered and unrelated to the purpose of the imaging. Incidental findings are increasingly detected in clinical practice, with screening, and in the research setting. Data on the prevalence of these abnormalities are scarce, the clinical course of the findings is often unknown, and—as a result—the management of such lesions is not clear. As a community, we need to set standards on how to deal with such findings.
In the linked study (doi:10.1136/bmj.b3016), Morris and colleagues systematically reviewed the literature on incidental findings on brain magnetic resonance imaging (MRI) and found a prevalence of 0.7% (95% confidence interval 0.47% to 0.98%) for neoplastic lesions including meningeoma (0.3%), and 2.0% (1.1% to 3.1%) for non-neoplastic lesions including aneurysms (0.4%).1 The authors state that they have increased the precision of existing estimates on
Aad van der Lugt, associate professor of radiology
1 Department of Radiology, Erasmus MC, University Medical Centre Rotterdam, 3015 CE Rotterdam, Netherlands
a.vanderlugt@erasmusmc.nl